GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Meridian Bioscience Inc (NAS:VIVO) » Definitions » Shiller PE Ratio

Meridian Bioscience (Meridian Bioscience) Shiller PE Ratio : 33.30 (As of May. 23, 2024)


View and export this data going back to 1986. Start your Free Trial

What is Meridian Bioscience Shiller PE Ratio?

As of today (2024-05-23), Meridian Bioscience's current share price is $33.97. Meridian Bioscience's E10 for the quarter that ended in Sep. 2022 was $1.02. Meridian Bioscience's Shiller PE Ratio for today is 33.30.

The historical rank and industry rank for Meridian Bioscience's Shiller PE Ratio or its related term are showing as below:

VIVO's Shiller PE Ratio is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 27.935
* Ranked among companies with meaningful Shiller PE Ratio only.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Meridian Bioscience's adjusted earnings per share data for the three months ended in Sep. 2022 was $0.130. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is $1.02 for the trailing ten years ended in Sep. 2022.

Shiller PE for Stocks: The True Measure of Stock Valuation


Meridian Bioscience Shiller PE Ratio Historical Data

The historical data trend for Meridian Bioscience's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Meridian Bioscience Shiller PE Ratio Chart

Meridian Bioscience Annual Data
Trend Sep13 Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 18.57 12.21 20.76 20.28 30.85

Meridian Bioscience Quarterly Data
Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.28 20.83 24.81 29.41 30.85

Competitive Comparison of Meridian Bioscience's Shiller PE Ratio

For the Diagnostics & Research subindustry, Meridian Bioscience's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Meridian Bioscience's Shiller PE Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Meridian Bioscience's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Meridian Bioscience's Shiller PE Ratio falls into.



Meridian Bioscience Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Meridian Bioscience's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=33.97/1.02
=33.30

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Meridian Bioscience's E10 for the quarter that ended in Sep. 2022 is calculated as:

For example, Meridian Bioscience's adjusted earnings per share data for the three months ended in Sep. 2022 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Sep. 2022 (Change)*Current CPI (Sep. 2022)
=0.13/125.2265*125.2265
=0.130

Current CPI (Sep. 2022) = 125.2265.

Meridian Bioscience Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201212 0.200 96.871 0.259
201303 0.240 98.209 0.306
201306 0.240 98.518 0.305
201309 0.220 98.790 0.279
201312 0.180 98.326 0.229
201403 0.240 99.695 0.301
201406 0.210 100.560 0.262
201409 0.200 100.428 0.249
201412 0.190 99.070 0.240
201503 0.240 99.621 0.302
201506 0.220 100.684 0.274
201509 0.200 100.392 0.249
201512 0.210 99.792 0.264
201603 0.210 100.470 0.262
201606 0.210 101.688 0.259
201609 0.130 101.861 0.160
201612 0.150 101.863 0.184
201703 0.220 102.862 0.268
201706 0.010 103.349 0.012
201709 0.130 104.136 0.156
201712 0.150 104.011 0.181
201803 0.120 105.290 0.143
201806 0.160 106.317 0.188
201809 0.130 106.507 0.153
201812 0.190 105.998 0.224
201903 0.170 107.251 0.198
201906 0.120 108.070 0.139
201909 0.100 108.329 0.116
201912 0.070 108.420 0.081
202003 0.220 108.902 0.253
202006 0.640 108.767 0.737
202009 0.150 109.815 0.171
202012 0.610 109.897 0.695
202103 0.600 111.754 0.672
202106 0.260 114.631 0.284
202109 0.150 115.734 0.162
202112 0.350 117.630 0.373
202203 0.650 121.301 0.671
202206 -0.170 125.017 -0.170
202209 0.130 125.227 0.130

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Meridian Bioscience  (NAS:VIVO) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Meridian Bioscience Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Meridian Bioscience's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Meridian Bioscience (Meridian Bioscience) Business Description

Traded in Other Exchanges
N/A
Address
3471 River Hills Drive, Cincinnati, OH, USA, 45244
Meridian Bioscience Inc is an integrated life science company. It develops and distributes diagnostic tests and reagents, as well as biologic substances used by pharmaceutical and biotechnology companies. Its Diagnostics segment manufactures tests primarily for gastrointestinal, viral, respiratory, & parasitic infectious diseases. Its testing platforms include isothermal DNA amplification, rapid immunoassays, and enzyme-linked immunoassays. The Life sciences segment sells b-antigens, antibodies, and reagents in bulk to other diagnostic manufacturers, the agriculture industry, and researchers. It also manufactures proteins that biopharmaceutical companies use in new drugs and vaccines. The entity has a business presence in the US and other countries.
Executives
Julie Diana Smith officer: Sr VP, Controller, PAO 3471 RIVER HILLS DRIVE, CINCINNATI OH 45244
John P. Kenny director, officer: Chief Executive Officer 3471 RIVER HILLS DRIVE, CINCINNATI OH 45244
Andrew S. Kitzmiller officer: EVP & CFO ONE BATESVILLE BLVD., BATESVILLE IN 47006
Bryan T Baldasare officer: Interim CFO & Chief Acctg Off 3471 RIVER HILLS DRIVE, CINCINNATI OH 45244
Rice John Mccune Jr. director 3471 RIVER HILLS DRIVE, CINCINNATI OH 45244
Bihl Anthony P Iii director 807 SMITH RIDGE ROAD, NEW CANAAN CT 06840
Tony Serafini-lamanna officer: Executive VP-Diagnostics 3471 RIVER HILLS DRIVE, CINCINNATI OH 45244
Felicia Williams director C/O MACY'S, INC., 151 WEST 34TH STREET, NEW YORK NY 10001
John Mcilwraith director 3471 RIVER HILLS DRIVE, CINCINNATI OH 45244
David Phillips director 3471 RIVER HILLS DRIVE, CINCINNATI OH 45244
James M. Anderson director 3471 RIVER HILLS DRIVE, CINCINNATI OH 45244
Dwight E Ellingwood director 3471 RIVER HILLS DRIVE, CINCINNATI OH 45244
Lawrence Baldini officer: Exec VP, Operations & IS 3471 RIVER HILLS DRIVE, CINCINNATI OH 45244
Eric S. Rasmussen officer: EVP, Bus. Development/Strategy 3471 RIVER HILLS DRIVE, CINCINNATI OH 45244
Lourdes Weltzien officer: EVP, Life Science 3471 RIVER HILLS DRIVE, CINCINNATI OH 45244

Meridian Bioscience (Meridian Bioscience) Headlines

From GuruFocus

Chuck Royce Buys 1, Sells 4 in 3rd Quarter

By GuruFocus Research GuruFocus Editor 11-03-2022

Top 5 2nd Quarter Trades of EARNEST PARTNERS LLC

By GuruFocus Research GuruFocus Editor 08-14-2022

Chuck Royce Buys 1, Sells 4 in 3rd Quarter

By GuruFocus Research GuruFocus Editor 11-03-2022